BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2893513)

  • 1. Tardive dyskinesia in schizophrenics. Prevalence, distribution and relationship to neurological "soft" signs in Nigerian patients.
    Gureje O
    Acta Psychiatr Scand; 1987 Nov; 76(5):523-8. PubMed ID: 2893513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tardive dyskinesia in schizophrenics under 60 years of age.
    Kolakowska T; Williams AO; Ardern M; Reveley MA
    Biol Psychiatry; 1986 Feb; 21(2):161-9. PubMed ID: 2868762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Nithsdale schizophrenia survey. V. Follow-up of tardive dyskinesia at 3 1/2 years.
    Robinson AD; McCreadie RG
    Br J Psychiatry; 1986 Nov; 149():621-3. PubMed ID: 2880631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Schizophrenics with tardive dyskinesia. Neuropsychological deficit and family psychopathology.
    Wegner JT; Catalano F; Gibralter J; Kane JM
    Arch Gen Psychiatry; 1985 Sep; 42(9):860-5. PubMed ID: 2864029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased tardive dyskinesia in alcohol-abusing schizophrenic patients.
    Dixon L; Weiden PJ; Haas G; Sweeney J; Frances AJ
    Compr Psychiatry; 1992; 33(2):121-2. PubMed ID: 1347498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and risk factors associated with tardive dyskinesia among Indian patients with schizophrenia.
    Achalia RM; Chaturvedi SK; Desai G; Rao GN; Prakash O
    Asian J Psychiatr; 2014 Jun; 9():31-5. PubMed ID: 24813033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurodevelopmental origins of tardivelike dyskinesia in schizophrenia patients and their siblings.
    Ismail B; Cantor-Graae E; McNeil TF
    Schizophr Bull; 2001; 27(4):629-41. PubMed ID: 11824489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tardive dyskinesia and impaired glucose tolerance.
    Chong SA; Mythily ; Lum A; Huak CY; Kane J
    Hum Psychopharmacol; 2002 Aug; 17(6):305-7. PubMed ID: 12404676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vulnerability to tardive dyskinesia.
    Wolf ME; DeWolfe AS; Ryan JJ; Lips O; Mosnaim AD
    J Clin Psychiatry; 1985 Sep; 46(9):367-8. PubMed ID: 2863257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and risk factors for tardive dyskinesia: a study in an Italian population of chronic schizophrenics.
    Altamura AC; Cavallaro R; Regazzetti MG
    Eur Arch Psychiatry Clin Neurosci; 1990; 240(1):9-12. PubMed ID: 1979540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The significance of subtyping tardive dyskinesia: a study of prevalence and associated factors.
    Gureje O
    Psychol Med; 1989 Feb; 19(1):121-8. PubMed ID: 2567019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tardive dyskinesia in chronic schizophrenic inpatients.
    Kua EH; Ang PC; Siew HC
    Singapore Med J; 1982 Feb; 23(1):19-21. PubMed ID: 6126008
    [No Abstract]   [Full Text] [Related]  

  • 13. The Nithsdale Schizophrenia survey: II. Abnormal movements.
    McCreadie RG; Barron ET; Winslow GS
    Br J Psychiatry; 1982 Jun; 140():587-90. PubMed ID: 6125227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The current prevalence and factors associated with tardive dyskinesia among Filipino schizophrenic patients.
    Go CL; Rosales RL; Caraos RJ; Fernandez HH
    Parkinsonism Relat Disord; 2009 Nov; 15(9):655-9. PubMed ID: 19346155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tardive dyskinesia in northern Israel: preliminary study.
    Schwartz M; Silver H; Tal I; Sharf B
    Eur Neurol; 1993; 33(3):264-6. PubMed ID: 8096816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tardive dyskinesia in the mentally retarded: comparison of prevalence, risk factors and topography with a schizophrenic population.
    Cohen S; Khan A; Zheng Y; Chiles J
    Acta Psychiatr Scand; 1991 Mar; 83(3):234-7. PubMed ID: 1674398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Withdrawal-emergent dyskinesia in patients with schizophrenia during antipsychotic discontinuation.
    Schultz SK; Miller DD; Arndt S; Ziebell S; Gupta S; Andreasen NC
    Biol Psychiatry; 1995 Dec; 38(11):713-9. PubMed ID: 8580223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prevalence of abnormal involuntary movements among chronic schizophrenics.
    Guy W; Ban TA; Wilson WH
    Int Clin Psychopharmacol; 1986 Apr; 1(2):134-44. PubMed ID: 3571941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tardive dyskinesia rates with atypical antipsychotics in adults: prevalence and incidence.
    Kane JM
    J Clin Psychiatry; 2004; 65 Suppl 9():16-20. PubMed ID: 15189107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tardive dyskinesia, mild drug-induced dyskinesia, and drug-induced parkinsonism: risk factors and topographic distribution.
    Akbostanci MC; Atbaşoğlu EC; Balaban H
    Acta Neurol Belg; 1999 Sep; 99(3):176-81. PubMed ID: 10544725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.